Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s disease

Fig. 1

TMSE decline-free survival under ChEI therapy. The Kaplan-Meier survival curves were plotted by setting the endpoint as a significant TMSE decline from the baseline for more than 2 points, for a all patients (N = 353, log rank test p-value = 0.001), b patients 60-years old or older (N = 308, log rank test p-value = 0.019), and c patients younger than 60-years old (N = 45, log rank test p-value = 0.071). Prominent MTA predicted shorter TMSE-decline free survival for patients 60-years old or older when starting ChEI therapy. TMSE Taiwanese Mini-Mental State Examination, ChEI cholinesterase inhibitor

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193